Retrospective Study: Neutrophil-to-Lymphocyte Ratio for Distinguishing Pulmonary Tuberculosis and Community-Acquired Pneumonia in Children
Keywords:
NLR, tuberculosis, community-acquired pneumoniaAbstract
Background and aim: Tuberculosis and pneumonia remain among the top ten causes of death in children under five. Clinical manifestations of pulmonary TB in children are mostly nonspecific and resemble acute pneumonia. The paucibacillary nature of TB in children contributes to diagnostic challenges. The neutrophil-to-lymphocyte ratio (NLR) is a straightforward biomarker that connects the innate and adaptive immune systems. This study aims to analyze the effectiveness of the NLR in distinguishing pulmonary tuberculosis (TB) from community-acquired pneumonia (CAP) in children.
Methods: This research is a retrospective case-control observational study based on medical record data of pediatric subjects with pulmonary TB or CAP treated at RSUD Dr. Soetomo. Characteristics and laboratory data were collected from medical records.
Results: A total of 50 subjects with pulmonary TB and 50 subjects with CAP demonstrated a significantly lower NLR in the pulmonary TB group (median 1.31; 0.23–5.62) vs. the CAP group (median 3.98; 1.19–53.51), p <0.001. The NLR differed significantly based on age. Pulmonary TB subjects aged <5 years old had a lower NLR (median 1.18; 0.23-5.00) compared to those >5 years old (median 2.89; 1.16-5.62) with p <0.001. Community-acquired pneumonia subjects aged <5 years old also had a lower NLR (median 3.79; 1.19-10.69) vs. >5 years old (median 6.79; 1.37-53.51) with p = 0.048. The cut-off <2.06 demonstrated good performance for differentiating pulmonary TB from CAP with high sensitivity (92%) and good specificity (68%).
Conclusions: The NLR is a useful biomarker to distinguish pulmonary TB from CAP in limited resource settings.
References
1. Desk Review: Pediatric Tuberculosis with a Focus on Indonesia. [Internet]. [cited 2025]. Available from: https://www.unicef.org/indonesia/reports/desk-review-pediatric-tuberculosis-focus-indonesia.
2. Global Tuberculosis report 2024. [Internet]. [cited 2025]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024.
3. Valvi C, Chandanwale A, Khadse S, et al. Delays and barriers to early treatment initiation for childhood tuberculosis in India. Int J Tuberc Lung Dis. 2019 Oct;23(10):1090–9. doi: 10.5588/ijtld.18.0439.
4. Yoon N, Son C, Um S. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med. 2013 Mar;33(2):105-10. doi: 10.3343/alm.2013.33.2.105.
5. Berhane M, Melku M, Amsalu A, Enawgaw B, Getaneh Z, Asrie F. The role of neutrophil to lymphocyte count ratio in the differential diagnosis of pulmonary tuberculosis and bacterial community-acquired pneumonia : a cross-Sectional Study at Ayder and Mekelle Hospitals, Ethiopia. Clin Lab. 2019 Apr;65(4):527-33. doi: 10.7754/Clin.Lab.2018.180833.
6. Laycock KM, Enane LA, Steenhoff AP. Tuberculosis in adolescents and young adults: emerging data on TB transmission and prevention among vulnerable young people. Trop Med Infect Dis. 2021 Aug;6(3):148. doi: 10.3390/tropicalmed6030148.
7. Nurjana MA, Laksono AD, Wartana IK, et al. Mycobacterium Tuberculosis infection among children under fifteen years of age: a population-based study in Indonesia. Asian Pac J Trop Med. 2023 November;16(11):506-14. doi: 10.4103/1995-7645.388387.
8. Nasrin S, Tariqujjaman M, Sultana M, et al. Factors associated with community acquired severe pneumonia among under five children in Dhaka, Bangladesh: a case control analysis. PLoS ONE. 2002 Mar;17(3):1-14. doi: 10.1371/journal.pone.0265871.
9. Oyana TJ, Minso J, Jones TL, McCullers JA, Arnold SR, Cormier SA. Particulate matter exposure predicts residence in high-risk areas for community acquired pneumonia among hospitalized children. Exp Biol Med. 2021 Sep;246(17):1907-16. doi: 10.1177/15353702211014456.
10. Mane SS, Shrotriya P. Current epidemiology of pediatric tuberculosis. Indian J Pediatr. 2024 Jul;91(7):711-6. doi: 10.1007/s12098-023-04910-4.
11. Nolt D, Starke JR. Tuberculosis infection in children and adolescents: testing and treatment. Pediatrics. 2021 Dec;148(6):e2021054663. doi: 10.1542/peds.2021-054663.
12. Musuenge BB, Poda GG, Chen PC. Nutritional status of patients with tuberculosis and associated factors in the health centre region of Burkina Faso. Nutrients. 2020 Aug;12(9):2540. doi: 10.3390/nu12092540.
13. Seramo RK, Awol SM, Wabe YA, Ali MM. Determinants of pneumonia among children attending public health facilities in Worabe Town. Sci Rep. 2022 Apr;12(1):6175. doi: 10.1038/s41598-022-10194-z.
14. Bramley AM, Reed C, Finelli L, et al. Relationship between body mass index and outcomes among hospitalized patients with community-acquired pneumonia. J Infect Dis. 2017 Jun;215(12):1873-82. doi: 10.1093/infdis/jix241.
15. Halvorson EE, Saha A, Forrest CB, et al. Associations between weight and lower respiratory tract disease outcomes in hospitalized children. Hosp Pediatr. 2022 Jul;12(8):734–42. doi: 10.1542/hpeds.2021-006404.
16. Chen L, Miao C, Chen Y, et al. Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia. Ital J Pediatr. 2021 Apr;47(1):100. doi: 10.1186/s13052-021-01042-3.
17. Yun KW, Wallihan R, Juergensen A, Mejias A, Ramilo O. Community-acquired pneumonia in children: myths and facts. Am J Perinatol. 2019 Jul;36(S 02):54-7. doi: 10.1055/s-0039-1691801.
18. Akahoshi S, Morikawa Y, Sakakibara H, et al. Risk factors of bacteremia in children hospitalized with community-acquired pneumonia: a nested case-control study. J Infect Chemother. 2021 Aug;27(8):1198-1204. doi: 10.1016/j.jiac.2021.03.016.
19. Wikanesthi D, Setyoningrum RA. Risk factors of bacteremia in children with community acquired pneumonia. Indian J Public Health Res Dev. 2021 Aug;11(8):254–60. doi: 10.37506/ijphrd.v11i8.10931.
20. Kobayashi SD, Malachowa N, DeLeo FR. Neutrophils and bacterial immune evasion. J Innate Immun. 2018;10(5-6):432-41. doi: 10.1159/000487756.
21. Korkmaz FT, Traber KE. Innate immune responses in pneumonia. Pneumonia. 2023 Feb;15(1):4. doi: 10.1186/s41479-023-00106-8.
22. Schuurman AR, Reijnders TDY, van Engelen TSR, et al. The host response in different aetiologies of community-acquired pneumonia. EbioMedicine. 2022 Jul;81:104082. doi: 10.1016/j.ebiom.2022.104082.
23. Vankayalapati R, Barnes PF. Innate and adaptive immune responses to human Mycobacterium Tuberculosis infection. Tuberculosis. 2009 Dec:89 Suppl 1:77-80. doi: 10.1016/S1472-9792(09)70018-6.
24. Mosleh T, Das N, Mutanabbi M. Role of neutrophil-lymphocyte ratio as a potential marker to differentiate between pulmonary tuberculosis and community-acquired pneumonia in children. Int J Contemp Pediatr. 2022 Nov;9(11):1022–6. doi: 10.18203/2349-3291.ijcp20222761
25. Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio : an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022 Mar;23(7):3636. doi: 10.3390/ijms23073636.
26. Cursi L, Lancella L, Mariani F, et al. Monocyte-to-lymphocyte, neutrophil-to-lymphocyte and neutrophil-to-monocyte plus lymphocyte ratios in children with active tuberculosis: a multicentre study. Acta Paediatr. 2023 Nov;112(11):2418-25. doi: 10.1111/apa.16932.
27. Xu M, Zhou L, Zhang J, Luo S, Zhao Y, Xiong W. Neutrophil to lymphocyte ratio in pediatric patients with asthmatic exacerbation and community-acquired pneumonia. BMC Pediatr. 2023 Dec;23(1):640. doi: 10.1186/s12887-023-04456-6.
28. Valiathan R, Ashman M, Asthana D. Effects of ageing on the immune system: infants to elderly. Scand J Immunol. 2016 Apr;83(4):255-66. doi: 10.1111/sji.12413.
29. Sulastri N, Alisjahbana B, Livia R, Sahiratmadja E. Higher neutrophil-lymphocyte ratio in TB/HIV co-infection compared to pulmonary tuberculosis. Indones Biomed J. 2021;13(4): 375-82. doi: 10.18585/inabj.v13i4.1698.
30. Goyes AB, Tuta-Quintero E, Arsanios DM, et al. Blood cell markers and acute phase reactants as a strategy to differentiate between pulmonary tuberculosis and community-acquired pneumonia: a retrospective cohort study. Infectio. 2023;27(4):210-6. doi: 10.22354/24223794.1148.
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.